Stokes Family Office’s Charles River Laboratories CRL Stock Holding History

Stokes Family Office’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$1.29M	Buy
2024 Q4	$1.4M	Sell
2024 Q3	$1.93M	Buy
2024 Q2	$1.72M	Buy
2024 Q1	$1.88M	Buy
2023 Q4	$1.2M	Buy
2023 Q3	$869K	Buy